Stay updated with breaking news from Colleen Tupper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) CFO Colleen Tupper sold 19,710 shares of the company’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $34.21, for a total transaction of $674,279.10. Following the completion of the sale, the chief financial officer now directly owns 130,845 […]
– Generated Record Quarterly and Full-Year Net Revenue of $149.7 Million and $566.8 Million – – Achieved Quarterly and Full-Year GAAP Net Income of $31.9 Million and $48.2 Million – ...
– Product Revenues, Net Expected in the Range of $580.0 Million to $595.0 Million – – Adjusted Operating Expenses* Expected in the Range of $120.0 Million to $125.0 Million – – Adjusted...
By Ben Glickman Shares of Collegium Pharmaceutical rose Wednesday after the specialty pharmaceutical company guided for higher revenue and adjusted earnings...
Operator: Greetings, and welcome to Collegium Pharmaceuticals Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.